Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
|
+$629M |
| 2 |
AGN
Allergan plc
AGN
|
+$463M |
| 3 |
State Street SPDR S&P Aerospace & Defense ETF
XAR
|
+$350M |
| 4 |
iShares Biotechnology ETF
IBB
|
+$315M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$265M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$978M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$675M |
| 3 |
Apple
AAPL
|
+$429M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$387M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$344M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.7% |
| 2 | Healthcare | 5.71% |
| 3 | Financials | 4.62% |
| 4 | Consumer Discretionary | 4.5% |
| 5 | Communication Services | 3.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2726
PUT
Darden Restaurants
DRI
$24.4B
| $2.17M | ﹤0.01% |
18,400
-7,500
| -29% | -$915K |
|
2727
PUT
Xylem
XYL
$28.1B
| $2.17M | ﹤0.01% |
27,300
+26,600
| +3,800% | +$2.09M |
|
2728
PUT
Exelixis
EXEL
$13.4B
| $2.17M | ﹤0.01% |
122,800
-1,600
| -1% | -$32.4K |
|
2729
Regenxbio
RGNX
$708M
| $2.17M | ﹤0.01% |
60,989
-7,288
| -11% | -$295K |
|
2730
Winnebago Industries
WGO
$909M
| $2.17M | ﹤0.01% |
56,656
-9,534
| -14% | -$347K |
|
|
HOLX
2731
PUT
DELISTED
Hologic
HOLX
| $2.17M | ﹤0.01% |
43,000
+40,500
| +1,620% | +$1.99M |
|
2732
CALL
Vanguard FTSE Europe ETF
VGK
$31.4B
| $2.17M | ﹤0.01% |
40,500
+24,200
| +148% | +$1.29M |
|
2733
Huntsman Corp
HUN
$1.77B
| $2.17M | ﹤0.01% |
93,370
-3,391
| -4% | -$70K |
|
2734
ProShares UltraPro QQQ
TQQQ
$37.9B
| $2.17M | ﹤0.01% |
281,232
+85,600
| +44% | +$678K |
|
2735
PUT
Direxion Daily Small Cap Bull 3x ETF
TNA
$1.46B
| $2.17M | ﹤0.01% |
38,900
-20,500
| -35% | -$1.19M |
|
2736
AMERISAFE
AMSF
$540M
| $2.16M | ﹤0.01% |
32,738
+9,289
| +40% | +$616K |
|
2737
Insulet
PODD
$9.79B
| $2.16M | ﹤0.01% |
13,108
-7,861
| -37% | -$1.1M |
|
2738
First Interstate BancSystem
FIBK
$3.58B
| $2.16M | ﹤0.01% |
53,712
+28,785
| +115% | +$1.13M |
|
2739
PUT
Tanger
SKT
$4.52B
| $2.16M | ﹤0.01% |
+139,500
| New | +$2.18M |
|
|
PRA
2740
DELISTED
ProAssurance
PRA
| $2.15M | ﹤0.01% |
53,505
-12,315
| -19% | -$477K |
|
2741
Kite Realty
KRG
$5.36B
| $2.15M | ﹤0.01% |
133,404
-39,912
| -23% | -$612K |
|
2742
FIVE9
FIVN
$2.54B
| $2.15M | ﹤0.01% |
40,025
+464
| +1% | +$26.1K |
|
2743
GoPro
GPRO
$126M
| $2.14M | ﹤0.01% |
412,937
-262,033
| -39% | -$1.23M |
|
2744
HealthEquity
HQY
$8.75B
| $2.14M | ﹤0.01% |
37,480
-40,871
| -52% | -$2.71M |
|
2745
First Financial Bankshares
FFIN
$4.97B
| $2.14M | ﹤0.01% |
64,143
-32,979
| -34% | -$1.04M |
|
2746
Ingevity
NGVT
$2.68B
| $2.14M | ﹤0.01% |
25,193
-11,153
| -31% | -$994K |
|
2747
Energizer
ENR
$1.55B
| $2.13M | ﹤0.01% |
48,996
-80,911
| -62% | -$3.22M |
|
2748
CALL
Pultegroup
PHM
$25.3B
| $2.13M | ﹤0.01% |
58,400
+4,300
| +8% | +$143K |
|
2749
CALL
Trane Technologies
TT
$106B
| $2.13M | ﹤0.01% |
17,300
+5,900
| +52% | +$720K |
|
2750
Beyond Meat
BYND
$277M
| $2.13M | ﹤0.01% |
14,331
+994
| +7% | +$164K |
|
Similar funds
Barclays's Q3 2019 Portfolio in Review
As of Q3 2019, Barclays held 7,551 positions worth $160B, down 2.1% from $163B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Barclays's Q3 2019 filing shows 501 new, 2,626 increased, 3,452 reduced and 568 closed positions. Its largest new stake was State Street SPDR S&P Aerospace & Defense ETF: 3,300,000 shares worth $353M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $978M.
By sector, the portfolio is most concentrated in Technology at 7.7% of assets, down from 8.5% a quarter earlier, followed by Healthcare and Financials.
- Barclays's largest Q3 2019 buy was State Street SPDR S&P Aerospace & Defense ETF: 3,300,000 shares worth $353M.
- Barclays added most to iPath Series B S&P 500 VIX Short-Term Futures ETN in Q3 2019, an estimated $629M increase.
- Barclays's biggest Q3 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $978M.
- Barclays fully exited Anadarko Petroleum in Q3 2019, selling an estimated $309M.
- Barclays's ten largest holdings make up 28% of its $160B portfolio in Q3 2019.
- Barclays opened 501 new positions and closed 568 in Q3 2019.
- Barclays's portfolio value fell 2.1% quarter-over-quarter to $160B.
Based on Barclays's 13F filing for Q3 2019, filed 14 Nov 2019.